Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_assertion type Assertion NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_head.
- NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_assertion wasGeneratedBy ECO_0000203 NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_provenance.
- NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_assertion wasDerivedFrom befree-20150227 NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_provenance.
- NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_assertion SIO_000772 11927838 NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_provenance.
- NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_assertion evidence source_evidence_literature NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_provenance.
- NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_assertion description "[Statistically significant increases in asthma risk were also observed among the whole study population for the concurrent presence of the GSTM1 null genotype and either NAT1 (odds ratio [OR] 4.53, 95% CI 1.76 to 11.6) or NAT2 (OR 3.12, 95% CI 1.11 to 8.78) slow acetylator genotypes, and of NAT1 and NAT2 slow acetylator genotypes (OR 4.20, 95% CI 1.51 to 11.6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857862.RAm2TGiXewH2_CWTkpmNqgo6--skivylgnMDiI4wYOnu0130_provenance.